High Mark Wealth Management LLC Viking Therapeutics, Inc. Transaction History
High Mark Wealth Management LLC
- $182 Million
- Q3 2024
A detailed history of High Mark Wealth Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 3,000 shares of VKTX stock, worth $141,690. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,000Holding current value
$141,690% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
474Shares Held
66.2MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$480 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$285 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$221 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$100 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$88.5 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.62B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...